MoneyWorks4Me

Wockhardt informs about press release

16 Aug 2022 Evaluate

Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1792.20
Dr. Reddys Labs. 1198.80
Cipla 1333.45
Lupin 2015.00
Zydus Lifesciences 1145.05
View more..